Over the last year, global supply chains and service providers have been affected by rising inflation, costs and challenges. Genotyping services and inputs in particular are affected by rising demand due to the global COVID-19 pandemic.
The CGIAR Excellence in Breeding Platform (EiB) has been proactive in maintaining the availability and quality of our brokered genotyping services throughout ongoing challenges. For 2022, there will be a small cost increase to our partners as a result of the higher prices charged by our trusted service partners.
The price of our brokered genotyping services remains extremely competitive and ensures we can continue to meet demand.
Starting April 1:
- The low-density genotyping service price will rise by 4.55%.
- The mid-density genotyping service price will cost an additional US $1 per sample.
Charge accounts filled before March 2022 will be honored at 2021 prices. See our notice for full details.
EiB remains committed to ensuring CGIAR and NARES breeding programs can access high-quality and affordable genotyping servicescontinue to work on ways to improve and streamline service delivery within One CGIAR.
Please contact us if you have concerns relating to budget or service provision.
